跳至主要内容
临床试验/NCT03954210
NCT03954210
已完成
不适用

SIESTA: Sleep Intervention to Enhance Cognitive Status and Reduce Beta Amyloid

University of Kansas Medical Center1 个研究点 分布在 1 个国家目标入组 200 人2019年8月27日
适应症Insomnia

概览

阶段
不适用
干预措施
未指定
疾病 / 适应症
Insomnia
发起方
University of Kansas Medical Center
入组人数
200
试验地点
1
主要终点
Stroop Test
状态
已完成
最后更新
9个月前

概览

简要总结

The objective of this study is to compare the efficacy of a sleep intervention on improving cognitive function in older adults with symptoms of insomnia, determine the association between change in sleep measures and change in cognitive function, and examine the efficacy of the sleep intervention on reducing the rate of Aβ deposition. Participants, ages 60-85, will be randomly assigned to a six-week sleep intervention program. A sub-group of fifty participants will undergo Florbetapir-Positron-emission tomography (PET) imaging during the one-year reassessment to examine the efficacy of the sleep intervention on reducing the rate of Aβ accumulation from baseline to one-year post-intervention.

详细描述

Lifestyle interventions to increase exercise and improve diet have been the focus of recent clinical trials to potentially prevent Alzheimer's disease (AD). However, despite the strong links between sleep disruptions, cognitive decline, and AD, sleep enhancement has yet to be targeted as a lifestyle intervention to prevent AD. Approximately fifteen percent of AD may be prevented by an efficacious intervention aimed to reduce sleep disturbances and sleep disorders. Chronic insomnia is the most frequent sleep disorder occurring in at least forty percent of older adults. Individuals with insomnia are more likely to be diagnosed with AD and demonstrate a decline in cognitive function at long-term follow-up. AD is characterized by the accumulation of Aβ plaques and tau tangles in the brain, and growing evidence shows impaired sleep contributes to the accumulation of Aβ. An intervention aimed at improving insomnia may represent a critical opportunity for primary prevention to slow cognitive decline and potentially delay the onset of AD. Therefore, the long-term goal of this research agenda is to understand how addressing sleep disturbances, via sleep intervention, may delay the onset of AD.

注册库
clinicaltrials.gov
开始日期
2019年8月27日
结束日期
2025年4月18日
最后更新
9个月前
研究类型
Interventional
研究设计
Parallel
性别
All

研究者

责任方
Sponsor

入排标准

入选标准

  • Report of difficulty falling asleep, maintaining sleep, or waking up too early at least three nights a week for the past six months
  • A score of greater than, or equal to, ten on the Insomnia Severity Index
  • A score of greater than, or equal to, twenty-five on the Mini-Mental State Examination (MMSE)
  • A score of less than, or equal to, two on the Dementia Screening Interview (AD8)

排除标准

  • A known untreated sleep disorder (i.e., sleep apnea or restless leg syndrome)
  • Currently taking benzodiazepines, non-benzodiazepines, melatonin supplements, or agonists for insomnia
  • A score of greater than, or equal to, fifteen on the Patient Health Questionnaire (PHQ-9) indicating severe depression or endorsement of any suicidal ideation (an answer of one, two, or three on item number nine of the PHQ-9)
  • History of drug or alcohol abuse as defined by the Diagnostic and Statistical Manual of Mental Disorders-IV (DSM-4) criteria within the last two years
  • History of a nervous system disorder (i.e., stroke, Parkinson's Disease)
  • Severe mental illness (i.e., Schizophrenia, Bipolar Disorder)
  • History of a learning disability or attention-deficit/hyperactivity disorder
  • Current, or history of, shift work
  • Currently receiving CBT-I treatment
  • Unable to hear at a conversational level

结局指标

主要结局

Stroop Test

时间窗: Baseline, 6-Week Reassessment, and One-Year Reassessment

Assessment of participants executive functioning. Participants will be required to inhibit their natural response and replace it with a different response (i.e., reading a word versus saying the color of the word). Scores are obtained by taking the difference between conditions and normalizing for the number of stimuli.

Continuous Performance Test (CPT)

时间窗: Baseline, 6-Week Reassessment, and One-Year Reassessment

Assessment of the participants attention. Participants will be given a set of rules for stimuli, and based on those rules they will determine if a presented stimuli fit within those rules. Scores will be determined by the number of correctly identified stimuli.

Repeatable Battery for the Assessment of Neuropsychological Status (RBANS)

时间窗: Baseline, 6-Week Reassessment, and One-Year Reassessment

Twelve sub-tests assessing participants immediate memory, visuospatial/constructional, language, attention, and delayed memory skills.Participants will engage in list learning, story memory, figure copying, line orientation, picture naming, semantic fluency, digit span, coding, list recall, list recognition, story memory and figure recall.

Neuropsychological Assessment Battery-Digits Forward/Digits Backward Test

时间窗: Baseline, 6-Week Reassessment, and One-Year Reassessment

Assessment of the participants attention and working memory. Participants will be required to remember and recall strings of numbers ranging from three to nine. Primary scores are obtained by tallying the number of trials the participant accurately recalled in the forward direction and the backward direction. Secondary scores are obtained by determining the longest string of numbers the participant recalled in the forward and backward direction.

次要结局

  • Polysomnography(Second Pre-Screening/Baseline, 6-Week Reassessment, and One-Year Assessment)

研究点 (1)

Loading locations...

相似试验